GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
R97.1
Elevated cancer antigen 125 [CA 125]
ICD10CM code
Similar Codes
ICD10CM codes
R97.1
- Elevated cancer antigen 125 [CA 125]
R97.0
- Elevated carcinoembryonic antigen [CEA]
R97.2
- Elevated prostate specific antigen [PSA]
R97.20
- Elevated prostate specific antigen [PSA]
R97
- Abnormal tumor markers
R97.8
- Other abnormal tumor markers
R97.21
- Rising PSA following treatment for malignant neoplasm of prostate
D07.5
- Carcinoma in situ of prostate
Z12.5
- Encounter for screening for malignant neoplasm of prostate
C25
- Malignant neoplasm of pancreas
HCPCS codes
G0103
- Prostate cancer screening; prostate specific antigen test (psa)
G8875
- Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
G9842
- Patient has metastatic disease at diagnosis
G9097
- Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as
G0101
- Cervical or vaginal cancer screening; pelvic and clinical breast examination
G0105
- Colorectal cancer screening; colonoscopy on individual at high risk
G0102
- Prostate cancer screening; digital rectal examination
S3854
- Gene expression profiling panel for use in the management of breast cancer treatment
C8937
- Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion
J9055
- Injection, cetuximab, 10 mg
CPT4 codes
86304
- Immunoassay for tumor antigen, quantitative; CA 125
81503
- Oncology (ovarian), biochemical assays of five proteins (CA-125, apolipoprotein A1, beta-2 microglob
81500
- Oncology (ovarian), biochemical assays of two proteins (CA-125 and HE4), utilizing serum, with menop
86301
- Immunoassay for tumor antigen, quantitative; CA 19-9
82378
- Carcinoembryonic antigen (CEA)
86300
- Immunoassay for tumor antigen, quantitative; CA 15-3 (27.29)
3374F
- AJCC Breast Cancer Stage I: T1c (tumor size > 1 cm to 2 cm) documented (ONC)
3315F
- Estrogen receptor (ER) or progesterone receptor (PR) positive breast cancer (ONC)
86153
- Cell enumeration using immunologic selection and identification in fluid specimen (eg, circulating t
86294
- Immunoassay for tumor antigen, qualitative or semiquantitative (eg, bladder tumor antigen)